Cargando…

Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells

BACKGROUND: Metformin is an approved drug prescribed for diabetes. Its role as an anti-cancer agent has drawn significant attention because of its minimal side effects and low cost. However, its mechanism of anti-tumour action has not yet been fully clarified. METHODS: The effect on cell growth was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demir, Ummuhan, Koehler, Andrea, Schneider, Rainer, Schweiger, Susann, Klocker, Helmut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929757/ https://www.ncbi.nlm.nih.gov/pubmed/24484909 http://dx.doi.org/10.1186/1471-2407-14-52

Ejemplares similares

A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signaling
por: Köhler, Andrea, et al.
Publicado: (2014)

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway
por: Chen, Chunyang, et al.
Publicado: (2021)

Active Transport of the Ubiquitin Ligase MID1 along the Microtubules Is Regulated by Protein Phosphatase 2A
por: Aranda-Orgillés, Beatriz, et al.
Publicado: (2008)

Alternative polyadenylation signals and promoters act in concert to control tissue-specific expression of the Opitz Syndrome gene MID1
por: Winter, Jennifer, et al.
Publicado: (2007)

Peptides disrupting TM4SF3 interaction with AR or AR-V7 block prostate cancer cell proliferation
por: Khatiwada, Prabesh, et al.
Publicado: (2023)

Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex
por: Schweiger, Susann, et al.
Publicado: (2017)

Dual Inhibitory Action of a Novel AKR1C3 Inhibitor on Both Full-Length AR and the Variant AR-V7 in Enzalutamide Resistant Metastatic Castration Resistant Prostate Cancer
por: Kafka, Mona, et al.
Publicado: (2020)

PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer
por: Puhr, M, et al.
Publicado: (2016)

Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC
por: White, Ralph E., et al.
Publicado: (2023)

Regulation of AR mRNA translation in response to acute AR pathway inhibition
por: Somasekharan, Syam Prakash, et al.
Publicado: (2021)

Drivers of AR indifferent anti-androgen resistance in prostate cancer cells
por: Handle, Florian, et al.
Publicado: (2019)

The Opitz syndrome gene product MID1 assembles a microtubule-associated ribonucleoprotein complex
por: Aranda-Orgillés, Beatriz, et al.
Publicado: (2008)

Increased expression of YAP1 in prostate cancer correlates with extraprostatic extension
por: Collak, Filiz Kisaayak, et al.
Publicado: (2017)

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
por: Narayanan, Ramesh
Publicado: (2020)

Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer
por: Wüstmann, Neele, et al.
Publicado: (2023)

Translation of Medical AR Research into Clinical Practice
por: Seibold, Matthias, et al.
Publicado: (2023)

A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer
por: Gu, Peng, et al.
Publicado: (2019)

Putative Prostate Cancer Risk SNP in an Androgen Receptor‐Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites
por: Bu, Huajie, et al.
Publicado: (2015)

AR, the cell cycle, and prostate cancer
por: Balk, Steven P., et al.
Publicado: (2008)

The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex
por: Hettich, Moritz M., et al.
Publicado: (2014)

Ar-turmerone inhibits the proliferation and mobility of glioma by downregulating cathepsin B
por: Cao, Wenpeng, et al.
Publicado: (2023)

Translating insights of AR signaling from mouse models
por: Carver, Brett S.
Publicado: (2013)

GABARAPL1 Promotes AR+ Prostate Cancer Growth by Increasing FL-AR/AR-V Transcription Activity and Nuclear Translocation
por: Su, Bing, et al.
Publicado: (2019)

Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer
por: Sugiura, Masahiro, et al.
Publicado: (2020)

Non-nuclear AR Signaling in Prostate Cancer
por: Zamagni, Alice, et al.
Publicado: (2019)

Correction: The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex
Publicado: (2014)

Somatic Alterations Impact AR Transcriptional Activity and Efficacy of AR-Targeting Therapies in Prostate Cancer
por: Chauhan, Gaurav, et al.
Publicado: (2021)

Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer
por: Khan, Farhan, et al.
Publicado: (2023)

Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid Culture
por: Eder, Theresa, et al.
Publicado: (2016)

Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program
por: Heidegger, Isabel, et al.
Publicado: (2015)

Baicalein suppresses the androgen receptor (AR)-mediated prostate cancer progression via inhibiting the AR N-C dimerization and AR-coactivators interaction
por: Xu, Defeng, et al.
Publicado: (2017)

ACK1–AR and AR–HOXB13 signaling axes: epigenetic regulation of lethal prostate cancers
por: Kim, Eric H, et al.
Publicado: (2020)

Huaier Extract Inhibits Prostate Cancer Growth via Targeting AR/AR-V7 Pathway
por: Liu, Zhengfang, et al.
Publicado: (2021)

Megakaryocyte-Derived IL-8 Acts as a Paracrine Factor for Prostate Cancer Aggressiveness through CXCR2 Activation and Antagonistic AR Downregulation
por: Dahal, Sadan, et al.
Publicado: (2023)

AR-Signaling in Human Malignancies: Prostate Cancer and Beyond
por: Schweizer, Michael T., et al.
Publicado: (2017)

AR Signaling in Human Malignancies: Prostate Cancer and Beyond
por: Antonarakis, Emmanuel S.
Publicado: (2018)

Coordinated AR and microRNA regulation in prostate cancer
por: Eringyte, Ieva, et al.
Publicado: (2020)

Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer
por: Jaiswal, Bharti, et al.
Publicado: (2022)

AR activates YAP/TAZ differentially in prostate cancer
por: Salem, Omar, et al.
Publicado: (2023)

A2AR Transmembrane 2 Peptide Administration Disrupts the A2AR-A2AR Homoreceptor but Not the A2AR-D2R Heteroreceptor Complex: Lack of Actions on Rodent Cocaine Self-Administration
por: Borroto-Escuela, Dasiel O., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_77de7h14dr7ooq4njbkd3649b8